Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Beicheng Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8657-7024; OpenAlex author ID A5014017713. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 7

  1. Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. Co-author DOI 10.1073/pnas.2511733123↗
  2. Inflammatory memory inactivates AMPK-stimulated DDR1 degradation to enable pancreatic cancer growth. Co-author DOI 10.1073/pnas.2616901123↗
  3. Corrigendum to "NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-I" [Drug … Last author DOI 10.1016/j.drup.2025.101269↗
  4. Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-025-09285-4↗
  5. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Last author DOI 10.1016/j.drup.2023.101040↗
  6. Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-023-05920-0↗
  7. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-022-05169-z↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Karin · 5 shared papers, 2022–2026 · strength 0.90
  2. Hua Su · 4 shared papers, 2022–2026 · strength 0.68
  3. Andrew M. Lowy · 4 shared papers, 2022–2026 · strength 0.65
  4. Wenjie Zhang · 2 shared papers, 2024–2025 · strength 0.52
  5. Zhiheng Zhang · 2 shared papers, 2024–2025 · strength 0.52
  6. David A. Brenner · 3 shared papers, 2022–2025 · strength 0.43
  7. Robert F. Schwabe · 3 shared papers, 2022–2025 · strength 0.43
  8. Christian M. Metallo · 3 shared papers, 2022–2025 · strength 0.43
  9. Fei Yang · 1 shared paper, 2026 · strength 0.25
  10. Dafna Bar‐Sagi · 1 shared paper, 2026 · strength 0.22
  11. Laura Antonucci · 1 shared paper, 2026 · strength 0.22
  12. Jonathan Weitz · 1 shared paper, 2026 · strength 0.22
  13. David W. Dawson · 1 shared paper, 2026 · strength 0.22
  14. Hervé Tiriac · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.